sufentanil has been researched along with nimodipine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dierssen, M; Flórez, J; Hurlé, MA | 2 |
| Dierssen, M; Flórez, J; Hurlé, MA; Ruiz, F | 2 |
| Díaz, A; Flórez, J; Hurlé, MA; Pazos, A; Ruíz, F | 2 |
| Barro, M; Hurlé, MA; Ruiz, F | 1 |
| Garaulet, JV; Laorden, ML; Milanés, MV | 1 |
| Díaz, A; Flórez, J; Hurlé, MA; Pazos, A | 2 |
| Hurlé, MA | 1 |
| Díaz, A; Garzón, J; Hurlé, MA; Mostany, R; Rodríguez-Muñoz, M; Valdizán, EM | 1 |
1 review(s) available for sufentanil and nimodipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
16 other study(ies) available for sufentanil and nimodipine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Opiate analgesia and calcium channels modulation by dihydropyridines under acute and tolerant conditions.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Analgesia; Animals; Calcium Channels; Dihydropyridines; Drug Tolerance; Fentanyl; Male; Nimodipine; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; Sufentanil | 1990 |
Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Analgesics, Opioid; Animals; Calcium Channels; Drug Interactions; Drug Tolerance; Fentanyl; Male; Nimodipine; Rats; Rats, Inbred Strains; Stereoisomerism; Sufentanil | 1990 |
Ca2+ channel modulation by dihydropyridines modifies sufentanil-induced respiratory depression in cats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Brain Stem; Calcium Channels; Cats; Female; Fentanyl; Male; Medulla Oblongata; Nimodipine; Respiration; Saline Solution, Hypertonic; Sufentanil | 1991 |
Regulation of dihydropyridine-sensitive Ca++ channels during opioid tolerance and supersensitivity in rats.
Topics: Analgesics, Opioid; Animals; Calcium; Calcium Channel Blockers; Dihydropyridines; Drug Synergism; Drug Tolerance; Ion Transport; Male; Nimodipine; Rats; Rats, Wistar; Sufentanil | 1995 |
Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system.
Topics: Analgesics, Opioid; Animals; Autoradiography; Calcium Channel Blockers; Calcium Channels; Central Nervous System; Drug Tolerance; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Male; Nimodipine; Rats; Rats, Wistar; Receptors, Opioid, mu; Sufentanil | 1995 |
Kappa-opioid receptor mediated antinociception in rats is dependent on the functional state of dihydropyridine-sensitive calcium channels.
Topics: Analgesics; Animals; Benzeneacetamides; Calcium Channels; Dihydropyridines; Dose-Response Relationship, Drug; Male; Nimodipine; Nociceptors; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa; Sufentanil | 1995 |
Potentiation of acute opioid-induced respiratory depression and reversal of tolerance by the calcium antagonist nimodipine in awake rats.
Topics: Animals; Depression, Chemical; Drug Synergism; Drug Tolerance; Injections, Subcutaneous; Male; Narcotics; Nimodipine; Plethysmography, Whole Body; Rats; Rats, Wistar; Respiration; Sufentanil | 1993 |
Effect of chronic administration of dihydropyridine Ca2+ channel ligands on sufentanil-induced tolerance to mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Analgesics, Opioid; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Dose-Response Relationship, Drug; Drug Tolerance; Female; Guinea Pigs; Ileum; Infusion Pumps, Implantable; Male; Myenteric Plexus; Nimodipine; Pyrrolidines; Sufentanil | 1996 |
Opioid tolerance and supersensitivity induce regional changes in the autoradiographic density of dihydropyridine-sensitive calcium channels in the rat central nervous system.
Topics: Animals; Autoradiography; Binding Sites; Calcium Channel Blockers; Calcium Channels; Central Nervous System; Dihydropyridines; Drug Resistance; Drug Tolerance; Male; Narcotics; Nimodipine; Rats; Rats, Wistar; Sufentanil | 2000 |
Autoradiographic mapping of mu-opioid receptors during opiate tolerance and supersensitivity in the rat central nervous system.
Topics: Analgesics, Opioid; Animals; Autoradiography; Brain Mapping; Calcium Channel Blockers; Central Nervous System; Drug Tolerance; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Ligands; Male; Narcotics; Nimodipine; Rats; Rats, Wistar; Receptors, Opioid, mu; Sufentanil | 2000 |
Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity.
Topics: Animals; Arrestins; beta-Adrenergic Receptor Kinases; beta-Arrestin 2; beta-Arrestins; Blotting, Western; Brain; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic AMP-Dependent Protein Kinases; Drug Tolerance; Enzyme Induction; G-Protein-Coupled Receptor Kinase 3; G-Protein-Coupled Receptor Kinases; Gene Expression Regulation; Male; Narcotics; Nerve Tissue Proteins; Nimodipine; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Receptors, Opioid, mu; Sufentanil | 2001 |
Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Topics: Adenylyl Cyclase Inhibitors; Analgesics, Opioid; Animals; Calcium Channel Blockers; Cyclic AMP; Data Interpretation, Statistical; Drug Tolerance; GTP-Binding Protein alpha Subunits, Gi-Go; Guanosine 5'-O-(3-Thiotriphosphate); Immunoprecipitation; Infusions, Intravenous; Male; Nimodipine; Pain Measurement; Pain Threshold; Pertussis Toxin; Rats; Rats, Wistar; Reaction Time; Receptors, Opioid, mu; Signal Transduction; Sufentanil | 2008 |